Admetsys' Unattributed Round

Admetsys raised a round of funding on June 06, 2017. Investors include T1D Exchange.

Admetsys is a biomedical technology company that has developed an artificial pancreas system for use in hospital and surgical care. Admetsys' treatment technology and supplementary remote monitoring p…

Articles about Admetsys' Unattributed Round: